JLL UK Clustering Insights

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Sarah Haywood, Managing Director of Advanced Oxford. Dive into the latest developments in Oxfordshire's science and technology landscape and discover the opportunities and challenges shaping the region's growth and innovation.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Olivia Drew, Portfolio Manager, UK Life Sciences at UBS as they discuss the opportunities across the UK and European market and why Life Sciences needs to be considered as a global sector for investment.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Professor Greg Clark, Chair of Connected Places Catapult and 3Ci. This episode delves into the role of innovation districts and the innovation economy's role in shaping the future of urbanisation as we continue to experience population growth and the drive to meet future sustainability requirements of the planet.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Hugo Villanueva, VC Investor at Octopus Ventures. The episode explores the opportunities for Life Sciences companies to gain venture capital funding but also, why social value is critical in driving success within the Life Sciences sector.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Jason Mellad, Co-Founder & CEO of Startcodon. This episode looks at the opportunities for scaling Life Sciences businesses to gain venture capital backing and the opportunities across the UK to bridge the gap between start-ups and value-add investors.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Harriet Fear MBE, Managing Director at Cambridge&.

This episode looks at how can the UK, especially Cambridge as part of the Golden Triangle retain its position as a world-leading centre for innovation. And how can the real estate sector meet the evolving needs of the Life Sciences industry when space is becoming increasingly limited?

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Kasia Averall, Head of Clusters at Cell and Gene Therapy Catapult.

In the podcast, they discuss a range of topics affecting the life sciences sector in the UK, from how to ensure your lab space is built and designed for innovation to thrive to the challenges in future-proofing a facility without knowing what the future may be. They also explore the requirements needed for GMP manufacturing space versus your traditional R&D space, and how you meet the regulatory requirements which accompany this.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Toby Reid, Executive Director at Pioneer Group, a company that helps build and operate life science campuses to help high-tech businesses thrive.

In the podcast they discuss a range of topics affecting the life sciences sector in the UK, from what makes a successful innovation ecosystem to how to build a flexible space in a market that’s changing at pace. They also debate which is more important in the real estate decision-making process – rental values or access to talent, and whether we can expect the UK market to remain a science and technology superpower post-Brexit.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Tony Jones, CEO of One Nucleus, the not-for-profit Life Sciences & Healthcare membership organisation.

In the podcast they discuss a range of topics affecting the life sciences sector in the UK, from how destination real estate locations can enable innovation and attract the best talent, to the pivotal role the government plays in the UK’s knowledge economy.

In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by John O’Driscoll, Global CIO & Head of Investment at AXA Investment Managers – Real Assets.

In the podcast they discuss AXA IM’s ambition and vision in the life sciences sector, focusing specifically on how ESG and societal benefit are key drivers in their investment decisions.